Vaginal Atrophy

• CLINICAL_TRIALS trial_result · 2010-07-27
  Clinical Trial Update: Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients [Phase 3]

  Phase 3 trial results update on Clino-san for managing vaginal dryness in breast cancer patients, highlighting efficacy and safety.

• FDA approval · 2008-08-25
  FDA Approved: ESTRING — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  The FDA approved a supplemental application for ESTRING (estradiol) submitted by Pfizer Laboratories Div Pfizer Inc.

• FDA approval · 2008-03-03
  FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

  The FDA approved a supplemental application for PREMARIN VAGINAL (conjugated estrogens) submitted by Wyeth Pharmaceuticals (Pfizer). This ac…

• CLINICAL_TRIALS trial_result · 2007-12-28
  Clinical Trial Update: Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause [Phase 3]

  Phase 3 trial evaluating bazedoxifene/conjugated estrogens for vasomotor symptoms of menopause has completed.

• CLINICAL_TRIALS trial_result · 2007-12-10
  Clinical Trial Update: Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis [Phase 3]

  A Phase 3 clinical trial evaluating conjugated estrogen cream for vaginal atrophy has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-02-14
  FDA Approved: FEMRING — Supplemental Application (Millicent US, Inc.)

  FDA approved a supplemental application for FEMRING (estradiol acetate) from Millicent US, Inc., updating/expanding the product's labeling p…

• FDA label_change · 2006-07-26
  FDA Approved: PREMARIN — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

  FDA approved a supplemental application for PREMARIN (conjugated estrogens), resulting in changes to the product labeling.